A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
Top Cited Papers
- 14 June 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (11) , 1949-1951
- https://doi.org/10.1212/01.wnl.0000163767.99354.c3
Abstract
A new botulinum toxin type A free of complexing proteins (NT 201) was compared with BOTOX in patients with cervical dystonia by means of a double-blind noninferiority trial. Four hundred sixty-three patients received IM injections of 70 to 300 U of NT 201 or BOTOX and were followed up over 16 weeks. The study clearly shows that NT 201 is at least as effective and safe as BOTOX.Keywords
This publication has 4 references indexed in Scilit:
- Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX°) in healthy volunteersJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystoniaZeitschrift für Neurologie, 2002
- One Man's Poison — Clinical Applications of Botulinum ToxinNew England Journal of Medicine, 1999
- Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic ConsequencesExperimental Neurology, 1997